Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPACA
NCT02564146Phase 2Completed
- Sponsor
- AIO-Studien
- Start
- Dec 2016
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, gemcitabine, sponsored by AIO-Studien. Started Dec 2016; status: completed.
02
Drugs
paclitaxelgemcitabine
Beyond the preview
Go deeper on NCT02564146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02564146.